Artificial intelligence (AI) technologies are progressing rapidly, presenting opportunities and intricate ethical and legal issues. This evaluation delineates modern methodologies and classifications ...

When it comes to trials of any drug, size matters, potentially giving the World Health Organization's (WHO) gloomy verdict on Gilead Sciences' COVID-19 treatment remdesivir an edge over the company's ...

While many organizations are doing away with their DEI programs amid political backlash, finding and hiring the best talent ...

New guidelines emphasize the need for clarity in consent agreements for clinical trials and aim to broaden participation in ...

Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many ...

A study of 848 companies shows that stagnation isn’t inevitable. Sign up for HBR Executive Agenda - for insights you need to steer your business now. Only available to HBR Executive subscribers.